Trump Official Drops Shocking Pre-Election Warning
The Trump administration is drawing attention to testosterone deficiency as a possible military-readiness issue, amid concerns that many young Americans are not physically eligible to serve.
“There is absolutely national defense readiness ramifications for [low testosterone],” Adm. Brian Christine, a senior Department of Health and Human Services official, told Fox News Digital. Christine helped shape the Pentagon’s screening initiative. He also cited estimates that 77% of Americans ages 17 to 24 cannot qualify for military service without a waiver, with obesity and chronic illness among the contributing factors.
The Pentagon’s guidance for male service members age 30 and older calls for screening during periodic health assessments and annual physicals. Younger personnel may be screened if they request it or a clinician identifies a reason. Screening is not an automatic prescription: treatment is voluntary and available when medically appropriate. The department temporarily withdrew an earlier version of the guidance in September to make updates, then reinstated a revised version.
War Secretary Pete Hegseth has presented the initiative as part of a broader effort to improve troop health and performance. “This initiative … is not about artificial enhancement,” he said, describing its goal as addressing a medical deficiency and supporting long-term health.
The debate involves more than military policy. The administration has cited concerns about declining testosterone levels among American men, while acknowledging that the causes and scale of any long-term decline remain under study. Obesity and chronic illness are established factors associated with lower testosterone; possible effects of environmental exposures are still being researched.
A recent study of active-duty Army personnel found that about one-quarter of the 479 men studied had at least one morning testosterone measurement below 300 nanograms per deciliter, a commonly used threshold. That result alone does not diagnose testosterone deficiency. The Endocrine Society says diagnosis should involve compatible symptoms and consistently low results confirmed with repeat morning testing; it also recommends against routine screening of men in the general population.
Medical organizations have questioned whether broad screening is supported by enough evidence, warning that it could lead to unnecessary diagnoses or treatment. Testosterone therapy can help some patients with confirmed deficiency, but it also carries risks. The Endocrine Society advises against starting treatment in men planning to have children in the near term, since therapy can impair fertility. Pentagon guidance likewise directs service members to discuss fertility with physicians before treatment.
Military clinicians must also account for factors that can temporarily affect hormone readings, including sleep loss, intense training, calorie restriction, illness and operational stress. Proper evaluation and follow-up are therefore central to distinguishing a persistent medical condition from a temporary change.
The Pentagon says it plans to issue separate hormonal-health guidance for female service members. For now, the testosterone-deficiency screening guidance applies to male personnel.